Bryan Giraudo - 06 Jan 2022 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
COO/CFO
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
06 Jan 2022
Net transactions value
$0
Form type
4
Filing time
10 Jan 2022, 15:05:48 UTC
Previous filing
20 Sep 2021
Next filing
24 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Award $0 +265,000 $0.000000 265,000 06 Jan 2022 Common Stock 265,000 $11.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the total number of shares subject to the option will vest on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.